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Osteoclasts are important target cells for osteoporosis treatment. Recently, a real-time cell analysis
(RTCA) system was developed to observe cell morphology and adhesion; however, the use of RTCA to
study osteoclastogenesis has not been reported. Here, we investigated whether osteoclast formation
could be monitored in real-time using RTCA. The cell index determined via electrical impedance using
RTCA, and the number of osteoclasts exhibited a signiﬁcant positive correlation. RTCA was useful for
determining the effect of ()-epigallocatechin-3-gallate on the inhibition of bone resorption. We
established a new method of measuring osteoclast formation in real-time using RTCA.
© 2015 Production and hosting by Elsevier B.V. on behalf of Japanese Pharmacological Society. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Osteoporosis is one of the most common causes of disability in
the elderly, leading to both hip and vertebral fractures (1). The
prevention of osteoporosis and its associated fractures is essential
to maintaining health, quality of life, and independence in the
elderly (2). Bone is constantly destroyed or resorbed by osteoclasts
and then replaced by osteoblasts during bone remodeling. Most
bone disorders, including osteoporosis, are caused by increased
bone resorption by osteoclasts (3). Therefore, osteoclasts serve as
key target cells for anti-osteoporosis therapies.
Osteoclast formation requires the presence of RANKL (receptor
activator of nuclear factor kb ligand) and M-CSF/CSF-1 (macro-
phage colony-stimulating factor/colony-stimulating factor-1). Both
of these membrane-bound proteins are necessary for osteoclasto-
genesis and are heavily involved in the differentiation of monocyte/
macrophage derived cells. Indeed M-CSF/CSF-1 stimulates the
fusion process in osteoclasts and/or their precursors (4) and also
increases bone resorption by increasing osteoclast size (5). It is
important to understand osteoclast morphology to develop newogy, Osaka Dental University,
121, Japan. Tel.: þ81 72 864
ano).
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r B.V. on behalf of Japanese Pharmdrug treatments for bone disease, but it is difﬁcult to study osteo-
clast morphology continuously (i.e., in real -time). Instead, osteo-
clasts are typically ﬁxed and stained with a dye such as tartrate-
resistant acid phosphatase (TRAP), and the stained cells are
examined by light microscopy (6). These assays as described are
end-point assays that, provide a ‘snapshot’ of the morphology
process (7).
Recently, the xCELLigence real-time cell analysis DP (Dual Plate)
system (RTCA; Scrum Inc., Tokyo, Japan) was developed to observe
cell morphology and cell adhesion using electrical impedance
in vitro (7, 8). This RTCA instrument is a proprietary microelectronic
biosensor system for cell-based assays. The core of the system is
composed microelectronic cell sensor arrays that are integrated
into the bottom of E-Plate 16. Measurements of the electronic
impedance of these sensor electrodes allow changes in the cell to be
detected and monitored. Cell viability, cell number, cell
morphology, and the degree of adhesion affect electrode imped-
ance. Impedance measured between electrodes in an individual
well depends on the electrode geometry, the ionic concentration in
the well, and whether cells are attached to the electrodes. In the
absence of cells, electrode impedance primarily depends on the
ionic environment, both at the electrode/solution interface and in
the bulk solution. In the presence of cells, the cells attached to the
electrode sensor surfaces act as insulators and thereby alter theacological Society. This is an open access article under the CC BY-NC-ND license
Fig. 1. Osteoclast precursor cells of 1.5 x 10⁵ cells/well were cultured for 3e8 days in the presence (AeF) or absence (negative control; GeI) of M-CSF/CSF-1 and RANKL. Media were
changed after 1 and 3 days. Osteoclasts were identiﬁed via tartrate-resistant acid phosphatase (TRAP) staining (original magniﬁcation x100). C) The red arrow indicates TRAP-
positive multinucleated giant osteoclasts. E) The yellow arrow indicates osteoclasts apoptosis. Osteoclast precursor cells of 1.0 x 10⁵ cells/well were cultured for 3e8 days in the
presence (JeO) or absence (negative control; PeR) of M-CSF/CSF-1 and RANKL. Media were changed after 1 and 3 days. Osteoclasts were identiﬁed via TRAP staining (original
magniﬁcation x100). M) The red arrow indicates TRAP-positive multinucleated giant osteoclasts. N) The yellow arrow indicates osteoclasts apoptosis.
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to increased impedance (7). No studies examined real-time changes
in osteoclast morphology have been published. In this study, we
examined a new method to capture the differentiation of osteo-
clasts in real-time. Moreover, we previously reported that
()-epigallocatechin-3-gallate (EGCG) inhibits the differentiation
of osteoclasts (6, 9). Therefore, we also investigated whether this
new RTCA method could monitor the effect of EGCG on osteoclasts.
We used 5- to 8 week-old ddY male mice (Sankyo Labo Service
Corporation, Inc., Tokyo, Japan). All experiments were conducted
according to the “Guiding Principles for the Care and Use of Labo-
ratory Animals” of The Japanese Pharmacological Society and with
the approval of the Showa University Animal Care and Use Com-
mittee (certiﬁcate number: 13041). M-CSF/CSF-1 and RANKL were
acquired from Pepro Tech (Rocky Hill, NJ, USA.). EGCG was pur-
chased from Wako Pure Chemical Industries Ltd. (Osaka, Japan).
We obtained bone marrow cells from the femur and tibia bones
of male mice and cultured them (1.0 x 10⁵ cells/well or 1.5 x 10⁵
cells/well) in an E-plate for RTCA and in a 96-well plate with me-
dium that contained 15% serum, 25 ng/mlM-CSF/CSF-1, and 100 ng/
ml RANKL. Media were changed after 1d and 3 d. We also culturedFig. 2. A) TRAP-positive multinucleated cells with more than three nuclei as determined by l
blue line represents osteoclast cells cultured at 1.5 x 10⁵ cells/well with M-CSF/CSF-1 and R
with M-CSF/CSF-1 and RANKL. Values are expressed as the mean ± S.E.M from 4 indepen
*P < 0.05, compared with 6 d in 1.0 x 10⁵ cells/well. B) The CI of osteoclastogenesis for 1.0 or 1
and 3 d. Values are expressed the mean ± S.E.M of 6 independent experiments. #P < 0.05, # #
with controls of 1.0 x 10⁵ cells/well. C) Correlation between the CI and the number of osteocla
CI and the number of osteoclasts was observed.cells in medium without M-CSF/CSF-1 and RANKL as negative
controls (10). Moreover, we cultured bone marrow cells (1.0 x 10⁵
cells/well) in an E-plate for RTCA and a 96-well plate with or
without 10 and 100 mM EGCG.
We stained cells with TRAP at 37 C for 20 min on days 3, 4, 5, 6,
7, and 8. We counted osteoclasts that were TRAP-positive and had
three or more nuclei (6, 10).
The results were expressed as the mean ± standard error of the
mean (S.E.M). The datawere analyzed using theManneWhitney U-
test. Correlations were calculated by Pearson's product moment
correlation coefﬁcient. P values less than 0.05 were considered
signiﬁcant.
Osteoclast precursor cells cultured at 1.5 x 10⁵ cells/well in
medium with M-CSF/CSF-1 and RANKL increased in size over the
course of 3 d, however, no osteoclasts were observed at 3 d (Fig.1A).
Osteoclasts ﬁrst appeared at 4 d (Fig. 1B). The largest osteoclast
(greater than 1 mm) was observed at 5 d (Fig. 1C; red arrow). Af-
terwards, osteoclasts became smaller due to apoptosis (Fig. 1D,
yellow arrow; 1E, F). However, osteoclast precursor cells cultured at
1.0 x 10⁵ cells/well inmediumwithM-CSF/CSF-1 and RANKL started
to increase in size at 3 d (Fig. 1J), but few osteoclasts were observedight microscopy were counted as osteoclasts. Media were changed after 1d and 3 d. The
ANKL. The red line represents osteoclast precursor cells cultured at 1.0 x 10⁵ cells/well
dent experiments. #P < 0.05, signiﬁcantly different from 5 d for 1.5 x 10⁵ cells/well.
.5 x 10⁵ cells/well with/without M-CSF/CSF-1 and RANKL. Media were changed after 1d
P < 0.01, compared with controls of 1.5 x 10⁵ cells/well. *P < 0.05, **P < 0.01, compared
sts. A highly signiﬁcant positive correlation (r ¼ 0.9423, p < 4.072  10e7) between the
H. Emori et al. / Journal of Pharmacological Sciences 128 (2015) 87e9190by 4 d (Fig. 1K). The largest osteoclast was observed at 6 d (red
arrow; Fig. 1M), and became smaller at 7 d (yellow arrow; Fig. 1-
NeO). Osteoclasts did not appear in the medium without M-CSF/
CSF-1 and RANKL until 8 days (Fig. 1 GeI, and PeR).
Fig. 2A shows the number of multinucleated (more than three)
osteoclasts in each well. In the medium cultured with 1.5 x 10⁵ cells/
well, the number of osteoclasts increased to 71.5 ± 4.9 at 4 days and
reached 331.5 ± 10.2 at 5 days. Thereafter, the number of osteoclasts
decreased over time. Similarly, in themedium culturedwith 1.0 x 10⁵
cells/well, the number of osteoclasts increased to 24.8 ± 0.7 at 4 d,
reached 242.8 ± 5.5 at 6 d, and then decreased over time.Fig. 3. Osteoclast precursor cells were cultured at 1.0 x 10⁵ cells/well for 72, 144, and 164 h w
and 3 days. Osteoclasts were identiﬁed via TRAP staining (original magniﬁcation x100). E)
positive multinucleated cells more than three nuclei as determined by light microscopy we
sents osteoclast cells cultured at 1.0 x 10⁵ cells/well with M-CSF/CSF-1 and RANKL (control).
without M-CSF/CSF-1 and RANKL. The green and broken red line represents osteoclast ce
expressed as the mean ± S.E.M of 4 independent experiments. **P < 0.01, compared with
without M-CSF/CSF-1 and RANKL or with 10 and 100 mM EGCG. Media were changed after
*P < 0.05, **P < 0.01, compared with control.A unitless parameter termed cell index (CI) was used tomeasure
the relative change in electrical impedance as a marker of cell
status. The CI is a relative and dimensionless value because it rep-
resents the impedance change divided by a background value (7, 8).
For osteoclast precursor cells cultured at 1.5 x 10⁵ cells/well in the
medium with M-CSF/CSF-1 and RANKL, the CI increased signiﬁ-
cantly for 71 h and reached maximum values (1.01 ± 0.09) at 5
d (Fig. 2B). For osteoclast precursor cells cultured at 1.0 x 10⁵ cells/
well with M-CSF/CSF-1 and RANKL, the CI increased signiﬁcantly
for 76 h and reached maximum values (0.71 ± 0.07) at 6 d. The CI
did not increase in osteoclast precursor cells cultured at 1.0 orithout (AeC) or with (DeF) 10 mM and (GeI) 100 mM EGCG. Media were changed after 1
The white arrow indicates TRAP-positive multinucleated small osteoclasts. G) TRAP-
re counted as osteoclasts. Media were changed after 1d and 3 d. The blue line repre-
J) The light blue line represents osteoclast precursor cells cultured at 1.0 x 10⁵ cells/well
lls cultured at 1.0 x 10⁵ cells/well with 10 and 100 mM EGCG, respectively. Values are
control. K) This graph shows the CI of osteoclastogenesis of 1.0 x 10⁵ cells/well with/
1d and 3 d. Values are expressed as the mean ± S.E.M of 8 independent experiments.
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The number of osteoclasts observed via TRAP staining and the CI by
RTCA were similar (Fig. 2A, B). A highly signiﬁcant positive corre-
lation (r ¼ 0.94, p < 4.1  10e7) between CI and the number of
osteoclasts is presented in Fig. 2C.
Fig. 3 presents cultured osteoclasts with or without 10 and
100 mM EGCG. EGCG (100 mM) strongly suppressed the cellecell
fusion and proliferation of osteoclast precursor cells. A small
number of multinucleated osteoclasts (white arrow; Fig. 3E) and
many small osteoclasts (uncountable level at themacroscopic level)
were observed at 144 hwhen culturedwith 10 mMEGCG. Fig. 3J and
K presents the number of osteoclasts via TRAP staining and ac-
cording to the CI by RTCAwith or without 10 and 100 mMEGCG. The
discrepancy between the ﬁgures is due to EGCG inhibition. RTCA
measures the CI values for the minute uncountable osteoclasts at
the macroscopic level. The CI level does not increase when osteo-
clasts do not differentiate. Therefore, CI levels may be more accu-
rate for the measurement of osteoclasts compared to macroscopic
measurements. However, we observed a signiﬁcant positive cor-
relation (r ¼ 0.7957, p < 7.850  10e5) between the CI and the
number of osteoclasts in the 10 mM EGCG and control groups.
We established a new method for real-time monitoring of
osteoclastogenesis using RTCA. It is difﬁcult to monitor osteoclas-
togenesis in real time using traditional endpoint assays. We
modiﬁed RTCA to allow for real-time monitoring of osteoclasto-
genesis. This new method offers the following advantages:
1) Real time monitoring
2) High reproducibility
3) Relatively simple and easy
4) High correlation with classic endpoint assays
Overall, these advantages appear to outweigh the limitations,
and we believe that RTCA will be advantageous for determining
ﬁxed-quantities of osteoclasts because RTCA has been proven
useful for assessing a ﬁxed-quantities of cells during migration and
invasion (11e14). However, it is difﬁcult to use RTCA to assess ﬁxed-
quantities of osteoclasts during migration and invasion because
osteoclasts exhibit a low CI. RTCA is useful for measuring the effect
of a compound (8, 11, 12). In fact, using RTCA to analyze changes in
osteoclasts was also useful for measuring the effects of EGCG in the
present study. Various reports have detailed numerous methods of
studying osteoclasts in vitro (6, 14, 15), but RTCA will likely become
a new essential tools.
It is potentially possible to determine the effects of various
compounds on osteoclasts using this new system. Consequently it
is possible that this new system can contribute to the development
of osteoporotic medications.Conﬂicts of interest
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